A look at how peptides went from an unfamiliar word a year ago to a common topic among friends, sisters and neighbors. Thin on specifics beyond the trend itself.
Recap by typeshit. Post by Facebook on Facebook.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
The Swiss drugmaker is licensing an investigational obesity candidate from the Chinese biotech, adding to its push into the weight loss drug race.
Obesity doctor Spencer Nadolsky weighs in on who has the standing to give advice on GLP-1 medications and peptides online.
Loading…